BSE filing, NSE: SAPTAK. Summary written from the filing by ALFA Finder's alert engine.
Saptak Chem And Business Ltd: key numbers
- Share price
- ₹21.85
- Market cap
- ₹6.71 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-0.30 Cr
- P/E (TTM)
- -22.5×Sector 36.4×
- Promoter holding
- 4.39%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saptak Chem And Business Ltd
All →Saptak Chem And Business Q2 FY27 Results: Net Profit ₹0 Cr
Saptak Chem And Business Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Saptak Chem And Business Board Meeting Date
Saptak Chem and Business Limited scheduled a board meeting for October 24, 2026, to approve the unaudited financial results for the quarter ended September 30, 2026.
Saptak Chem And Business Annual General Meeting
Saptak Chem and Business Limited held its 47th Annual General Meeting on August 29, 2026, via video conferencing. Shareholders transacted ordinary and special business items during the meeting.
Saptak Chem And Business Annual General Meeting
Saptak Chem and Business Limited issued a corrigendum to its 47th AGM notice, rescheduling the meeting to August 29, 2026, and updating director appointment dates.
Saptak Chem And Business Annual Report
Saptak Chem and Business Limited has submitted its 47th Annual Report for the financial year 2025-26 to the BSE. The report is now available for shareholder reference.
Saptak Chem And Business Annual General Meeting
Saptak Chem and Business Limited issued notice for its 47th Annual General Meeting, scheduled for August 28, 2026, via video conferencing.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.